Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06128915 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion pushed from May 31, 2026 to May 31, 2027v5
  2. Primary completion date: May 1, 2026 to May 31, 2026v4
  3. Re-verified, no change to tracked fieldsv3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study focuses on the role of neutrophils in shaping the adaptive immune response to the anti-pneumococcal vaccine Prevnar-13 in young and elderly adults.
Trial Details
NCT Number NCT06128915
Lead Sponsor State University of New York at Buffalo
Collaborators: National Institute on Aging (NIA)
Conditions
(from sponsor)		 Aging
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov